Premium
Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study
Author(s) -
Rajagopal Meena U.,
Hathout Yetrib,
MacDonald Tobey J.,
Kieran Mark W.,
Gururangan Sri,
Blaney Susan M.,
Phillips Peter,
Packer Roger,
GordishDressman Heather,
Rood Brian R.
Publication year - 2011
Publication title -
proteomics – clinical applications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 54
eISSN - 1862-8354
pISSN - 1862-8346
DOI - 10.1002/prca.201190065
Subject(s) - medulloblastoma , cerebrospinal fluid , biomarker , proteomics , biomarker discovery , brain tumor , medicine , computational biology , bioinformatics , pathology , biology , gene , genetics
This article was originally published in Proteomics 2011, 11 , 935–943, DOI 10.1002/pmic.201000198
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom